Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 21 Nov 2020)

 

Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study
HIV, HBV and HCV infections continue to represent major health concerns, especially among key at-risk populations such as men who have sex with men (MSM), people who inject drugs (PWIDs), transgender women (TG…
Authors: Ruxandra Calin, Véronique Massari, Gilles Pialoux, Nelly Reydellet, Eve Plenel, Carole Chauvin, Marie Jauffret-Roustide, Nesrine Day, Georges Kreplak, Anaenza Freire Maresca, Nicolas Derche, Sandra Louis, Stanislas Pol, Véronique Doré, Christine Rouzioux and Pierre Chauvin
Citation: BMC Infectious Diseases 2020 20:851
Content type: Research article
Published on: 16 November 2020